These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24129130)

  • 1. The BeSt way of withdrawing biologic agents.
    Allaart CF; Lems WF; Huizinga TW
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S14-8. PubMed ID: 24129130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
    Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA;
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy.
    Bergstra SA; Landewé RBM; Huizinga TWJ; Allaart CF
    Rheumatology (Oxford); 2017 Oct; 56(10):1721-1728. PubMed ID: 28957556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.
    Allaart CF; Breedveld FC; Dijkmans BA
    J Rheumatol Suppl; 2007 Nov; 80():25-33. PubMed ID: 17985420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
    van der Kooij SM; le Cessie S; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Zeben D; Kerstens PJ; Hazes JM; van Schaardenburg D; Breedveld FC; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2009 Jul; 68(7):1153-8. PubMed ID: 18930988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.
    Klarenbeek NB; Güler-Yüksel M; van der Kooij SM; Han KH; Ronday HK; Kerstens PJ; Seys PE; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Jun; 70(6):1039-46. PubMed ID: 21415052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.
    van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; van Zeben D; Kerstens PJ; Gerards AH; van Groenendael JH; Hazes JM; Breedveld FC; Allaart CF; Dijkmans BA
    Ann Rheum Dis; 2007 Oct; 66(10):1356-62. PubMed ID: 17293364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.
    van der Kooij SM; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Güler-Yüksel M; Zwinderman AH; Kerstens PJ; van der Lubbe PA; de Beus WM; Grillet BA; Ronday HK; Huizinga TW; Breedveld FC; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2009 Jun; 68(6):914-21. PubMed ID: 18662933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study.
    van den Broek M; Klarenbeek NB; Dirven L; van Schaardenburg D; Hulsmans HM; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Aug; 70(8):1389-94. PubMed ID: 21515916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
    Chang CY; Meyer RM; Reiff AO
    Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis.
    van der Bijl AE; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Ten Wolde S; Han KH; van Krugten MV; Allaart CF; Breedveld FC; Dijkmans BA
    Arthritis Rheum; 2007 Jul; 56(7):2129-34. PubMed ID: 17599726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
    Heimans L; Akdemir G; Boer KV; Goekoop-Ruiterman YP; Molenaar ET; van Groenendael JH; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Arthritis Res Ther; 2016 Jan; 18():23. PubMed ID: 26794605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry.
    Favalli EG; Pregnolato F; Biggioggero M; Becciolini A; Penatti AE; Marchesoni A; Meroni PL
    Arthritis Care Res (Hoboken); 2016 Apr; 68(4):432-9. PubMed ID: 26556048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.
    Heimans L; Wevers-de Boer KV; Visser K; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Speyer I; de Buck MP; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Ann Rheum Dis; 2014 Jul; 73(7):1356-61. PubMed ID: 23716067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission.
    Nawata M; Saito K; Nakayamada S; Tanaka Y
    Mod Rheumatol; 2008; 18(5):460-4. PubMed ID: 18535759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.
    Ferraccioli GF; Assaloni R; Di Poi E; Gremese E; De Marchi G; Fabris M
    Rheumatology (Oxford); 2002 Oct; 41(10):1109-12. PubMed ID: 12364628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.
    Zhang J; Xie F; Delzell E; Yun H; Lewis JD; Haynes K; Chen L; Beukelman T; Saag KG; Curtis JR
    Arthritis Care Res (Hoboken); 2015 May; 67(5):624-32. PubMed ID: 25370912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BeSt practice: the success of early-targeted treatment in rheumatoid arthritis.
    van den Broek M; Lems WF; Allaart CF
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S35-8. PubMed ID: 23078756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it possible to withdraw biologics from therapy in rheumatoid arthritis?
    Tanaka Y; Hirata S
    Clin Ther; 2013 Dec; 35(12):2028-35. PubMed ID: 24290736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.
    Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Allaart CF; van Zeben D; Kerstens PJ; Hazes JM; Zwinderman AH; Ronday HK; Han KH; Westedt ML; Gerards AH; van Groenendael JH; Lems WF; van Krugten MV; Breedveld FC; Dijkmans BA
    Arthritis Rheum; 2005 Nov; 52(11):3381-90. PubMed ID: 16258899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.